Point72 Hong Kong LTD Danaher Corp Call Options Transaction History

Point72 Hong Kong LTD

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$247.06 - $1507.4 $123,530 - $753,700	500 Added 13.89%	4,100 $1.06 Million
Q2 2022 Aug 15, 2022	SELL	$237.11 - $299.66 $450,509 - $569,354	-1,900 Reduced 34.55%	3,600 $913,000
Q1 2022 May 16, 2022	SELL	$257.27 - $315.76 $77,181 - $94,728	-300 Reduced 5.17%	5,500 $1.61 Million
Q4 2021 Feb 14, 2022	SELL	$292.08 - $329.01 $788,616 - $888,327	-2,700 Reduced 31.76%	5,800 $1.91 Million
Q3 2021 Nov 15, 2021	SELL	$272.21 - $332.43 $3.59 Million - $4.39 Million	-13,200 Reduced 60.83%	8,500 $2.59 Million
Q2 2021 Aug 16, 2021	BUY	$225.08 - $271.69 $4.39 Million - $5.3 Million	19,500 Added 886.36%	21,700 $5.82 Million
Q1 2021 May 17, 2021	BUY	$212.38 - $245.9 $467,236 - $540,980	2,200 New	2,200 $495,000

2,511

539M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $168B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.